Literature DB >> 20595167

Impact of adverse drug reaction and predictivity of quality of life status in tuberculosis.

N Guo, F Marra, J M Fitzgerald, R K Elwood, C A Marra.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20595167     DOI： 10.1183/09031936.00159409

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  13 in total

1.  Cost-effectiveness of a 12-dose regimen for treating latent tuberculous infection in the United States.

Authors:  D Shepardson; S M Marks; H Chesson; A Kerrigan; D P Holland; N Scott; X Tian; A S Borisov; N Shang; C M Heilig; T R Sterling; M E Villarino; W R Mac Kenzie
Journal:  Int J Tuberc Lung Dis       Date:  2013-12       Impact factor: 2.373

Review 2.  Quality of life in children with adverse drug reactions: a narrative and systematic review.

Authors:  Blanca R Del Pozzo-Magaña; Michael J Rieder; Alejandro Lazo-Langner
Journal:  Br J Clin Pharmacol       Date:  2015-07-02       Impact factor: 4.335

3.  Factors associated with health-related quality of life among pulmonary tuberculosis patients in Manila, the Philippines.

Authors:  Shoichi Masumoto; Taro Yamamoto; Akihiro Ohkado; Shoji Yoshimatsu; Aurora G Querri; Yasuhiko Kamiya
Journal:  Qual Life Res       Date:  2013-11-22       Impact factor: 4.147

4.  Construct and concurrent validity of a patient-reported adverse drug event questionnaire: a cross-sectional study.

Authors:  Sieta T de Vries; Flora M Haaijer-Ruskamp; Dick de Zeeuw; Petra Denig
Journal:  Health Qual Life Outcomes       Date:  2014-08-13       Impact factor: 3.186

5.  The Impact of Experiencing Adverse Drug Reactions on the Patient's Quality of Life: A Retrospective Cross-Sectional Study in the Netherlands.

Authors:  Leàn Rolfes; Florence van Hunsel; Katja Taxis; Eugène van Puijenbroek
Journal:  Drug Saf       Date:  2016-08       Impact factor: 5.606

6.  Evaluation of health-related quality of life in patients with tuberculosis who completed treatment in Kiribati.

Authors:  Cheng-Ting Li; Kuei-Hui Chu; Bereka Reiher; Takeieta Kienene; Li-Yin Chien
Journal:  J Int Med Res       Date:  2017-03-16       Impact factor: 1.671

7.  Risk factors for acute liver failure among inpatients with anti-tuberculosis drug-induced liver injury.

Authors:  Shuting Wang; Yanwan Shangguan; Cheng Ding; Pengcheng Li; Zhongkang Ji; Jundan Shao; Hong Fang; Meifang Yang; Pei Shi; Jie Wu; Jingjing Ren; Shigui Yang; Jing Yuan; Yunzhen Shi; Jingnan Li; Lanjuan Li; Kaijin Xu
Journal:  J Int Med Res       Date:  2018-11-26       Impact factor: 1.671

8.  Influence of efavirenz pharmacokinetics and pharmacogenetics on neuropsychological disorders in Ugandan HIV-positive patients with or without tuberculosis: a prospective cohort study.

Authors:  Jackson K Mukonzo; Alphonse Okwera; Neoline Nakasujja; Henry Luzze; Deogratious Sebuwufu; Jasper Ogwal-Okeng; Paul Waako; Lars L Gustafsson; Eleni Aklillu
Journal:  BMC Infect Dis       Date:  2013-06-04       Impact factor: 3.090

9.  Effects of Multidrug Resistant Tuberculosis Treatment on Patients' Health Related Quality of Life: Results from a Follow Up Study.

Authors:  Nafees Ahmad; Arshad Javaid; Syed Azhar Syed Sulaiman; Anila Basit; Afsar Khan Afridi; Ammar Ali Saleh Jaber; Amer Hayat Khan
Journal:  PLoS One       Date:  2016-07-28       Impact factor: 3.240

Review 10.  Quality of life with tuberculosis.

Authors:  Ashutosh N Aggarwal
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2019-09-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.